Question 1

What is the catalog number for NS-2710?

Accepted Answer

The catalog number for NS-2710 is M34351.

Question 2

What sizes are available for NS-2710?

Accepted Answer

NS-2710 is available in the following size(s): 1 g, 500 mg, 200 mg, 5 mg, 10 mg, 25 mg, 50 mg.

Question 3

How many pack sizes does NS-2710 come in?

Accepted Answer

NS-2710 is available in 7 different pack sizes.

Question 4

Is NS-2710 in stock?

Accepted Answer

NS-2710 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is NS-2710 used for?

Accepted Answer

NS-2710 is a non-selective GABA (A) receptor partial agonist for the study of anxiety disorders.

Question 6

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 7

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 8

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

NS-2710

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

AMPD3 Antibody

Lentiviral human PRDM15 sgRNA gene knockout kit - Lentiviral human PRDM15 sgRNA gene knockout kit (25)

Sec23a (NM_001105732) Rat Tagged ORF Clone Lentiviral Particle

Aquaporin 7 (AQP-7) Human ELISA Kit

Monkey Soluble CD36 ELISA kit

Hist1h4b sgRNA CRISPR Lentivector (Rat) (Target 3)